RetractedArticleMolecular cancer therapeutics2012

Proteasome inhibition blocks NF-κB and ERK1/2 pathways, restores antigen expression, and sensitizes resistant human melanoma to TCR-engineered CTLs.

Ali R Jazirehi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.